We are happy to announce our participation at this year’s European Meeting for Hair Research in Sheffield, UK on 14-16th June 2023. Meet Dr. Marta Bertolini, Acting CEO & CSO, Dr. Alizée Le Riche, Team Leader and Marta Lousada, Junior Staff Scientist in …
A new in vivo humanized mouse model for atopic dermatitis research and pre-clinical investigation of therapeutics
In this study, recently published in the high-ranking scientific journal Allergy the authors, including our founder Prof. Ralf Paus and acting CEO Dr. Marta Bertolini, describe the development of a novel humanized mouse model of AD that reflects the most …
Press Release: Monasterium Laboratory has successfully passed the first surveillance audit for the ISO9001:2015 Certification!
We are proud to announce that we have successfully passed the first surveillance audit for maintaining the ISO9001:2015 Certification from the TÜV Rheinland with the scope of: “Execution of state-of-the-art preclinical and clinical services for cosmetology, dermatology, nutraceutical, and allergy …
Meet us at the DDD EU summit 2023 in Berlin
We are happy to announce our participation at this year’s Dermatology Drug Development Summit Europe in Berlin, Germany on May 22-24, 2023. Meet Dr. Marta Bertolini, Acting CEO & CSO, in the exhibition area and don’t miss her talk on “Clinically …
Our Participation in the First International Societies For Investigative Dermatology (ISID) Meeting
Our team is excited to announce our participation in the upcoming International Societies for Investigative Dermatology Meeting (ISID) in Tokyo, Japan. This conference is a leading global platform for scientists, researchers, and clinicians to share their latest research and innovations in the …
New Webinar on Models and Assays for Atopic Dermatitis Research
On March 21st, 2023, we have held our free webinar dedicated to models for Atopic Dermatitis research presented by Anasua Pal (Monasterium Laboratory) and Samuel Guenin (QIMA Life Sciences). We focused on our models and assays for atopic dermatitis research …
Research Highlight: A new application for a commonly used drug? Statins as companion drug therapy in the treatment of Alopecia Areata
The USA, UK and Europe have recently approved the JAK inhibitor baricitinib/Olumiant® to treat severe cases of adult alopecia areata (AA). However, despite these good news, JAK inhibitors are still in an early stage of clinical investigation and until now …
Meet us at the in-cosmetics global 2023 in Barcelona
We are happy to announce our participation at this year’s in-cosmetics global in Barcelona, Spain on March 28-30, 2023. Meet our team in the QIMA Life Sciences stand AA40! Dr. Leslie Ponce and Dr. Gill Westgate will be happy to …
Press Release – New Publication: An advocacy to use humanized mouse models for psoriasis research and pre-clinical drug development
Psoriasis is a chronic inflammatory skin disease characterized by dry, itchy and scaly patches. Patients suffer greatly from both, the negative features of the symptoms as well as psychologically from i.e. poor self-esteem or social isolation. For the development of …
Service – single cell RNA sequencing
Are you interested in characterizing pathological cell subtypes, identifying rare cell types or analysing differentiation pathways in non-lesional vs. lesional skin? Do you want to dig deeper, and explore gene regulatory networks underlying immune system changes in immune-mediated skin disorders? …